Episode Details

In our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell sit down with Vantage Hemp CEO Rusty Kuchta and Chief Medical Officer Dr. Paul Shields to discuss one of the most important healthcare developments happening in the cannabinoid space today: the CMS CBD Pilot Program.While many investors remain focused on cannabis rescheduling and capital markets, this conversation takes a closer look at what could become the foundation for long-term medical adoption of cannabinoid therapies across the United States.The discussion covers how pharmaceutical-grade CBD is being evaluated inside value-based healthcare models, why physician education remains a major hurdle, and what healthcare providers, ACOs, insurers, and policymakers are learning as the pilot begins to take shape.Rusty and Dr. Shields explain why collecting real-world evidence is critical, how patient outcomes are measured, what pharmaceutical-grade manufacturing actually means, and why many healthcare organizations are still unaware that this opportunity even exists.If successful, the CMS pilot could become an important stepping stone toward broader insurance coverage, physician adoption, and long-term integration of cannabinoid-based therapies into the U.S. medical system.#CannabisIndustry #CBDPilotProgram#MedicalCannabis #CMS#HealthcareInnovation #Cannabinoids#ScheduleIII #PharmaceuticalGradeCBD#ValueBasedCare #TradeToBlackWant to see more Cannabis Reform?🎬    • Trulieve Becomes First Cannabis MSO Approv...  🎬    • Cannabis Stocks Arrive On Robinhood | TDR ...  🎬    • Why Virginia’s Governor Really Vetoed Cann...  🎬    • IRS Tax Guidance Could Boost Cannabis Prof...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:

Listen Now